Macular degeneration Trials in Phoenix, United States
Conditions / Macular degeneration / Phoenix, United States
Macular degeneration is a medical condition with active clinical research programs worldwide.
28 total trials for this combination
Showing top 10 of 28 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02462486 | Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | COMPLETED | PHASE3 |
| NCT00509795 | Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) | COMPLETED | PHASE3 |
| NCT06779773 | A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy | RECRUITING | — |
| NCT03805100 | Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD | COMPLETED | PHASE3 |
| NCT02462928 | A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | COMPLETED | PHASE3 |
| NCT03894020 | GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) | TERMINATED | — |
| NCT03815825 | GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) | COMPLETED | PHASE2 |
| NCT05839041 | A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06779773 | A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy | RECRUITING | — |
| NCT01134055 | Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration | COMPLETED | PHASE2 |